Literature DB >> 11446735

Complex karyotype and absence of mutation in the c-kit receptor in aggressive mastocytosis presenting with pelvic osteolysis, eosinophilia and brain damage.

E Jost1, L Michaux, M Vanden Abeele, B Boland, D Latinne, C Godfraind, J M Scheiff, J L Vaerman, F Lecouvet, A Ferrant.   

Abstract

Aggressive mastocytosis is a form of systemic mast cell disease (SMCD) characterized by organ infiltration, bone lesions. eosinophilia and lymphadenopathies. Here we report a patient with unusual clinical features, namely osteolysis without other bone lesions commonly found in SMCD, major eosinophilia and cerebral infarction. The mast cells exhibited a classical immunophenotype (CD2+, CD9+, CD13+, CD25+, CD35+, CD45c+ and CD117+). Cytogenetic investigation showed novel complex aberrations, and clonal evolution was correlated with clinical progression. The screening for recurrent point mutations affecting the c-kit gene was negative. Mainly, the ASP816VAL substitution was not detected in our patient. Treatment with steroids and interferon was only temporarily effective.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11446735     DOI: 10.1007/s002770000271

Source DB:  PubMed          Journal:  Ann Hematol        ISSN: 0939-5555            Impact factor:   3.673


  4 in total

Review 1.  Systemic mast cell activation disease: the role of molecular genetic alterations in pathogenesis, heritability and diagnostics.

Authors:  Britta Haenisch; Markus M Nöthen; Gerhard J Molderings
Journal:  Immunology       Date:  2012-11       Impact factor: 7.397

2.  CD117 expression in glial tumors.

Authors:  Neslihan Cetin; Gerald Dienel; Murat Gokden
Journal:  J Neurooncol       Date:  2005-11       Impact factor: 4.130

3.  Tetraspanins in mast cells.

Authors:  Martin Köberle; Susanne Kaesler; Wolfgang Kempf; Florian Wölbing; Tilo Biedermann
Journal:  Front Immunol       Date:  2012-05-07       Impact factor: 7.561

4.  The study of CD117 expression in glial tumors and its relationship with the tumor-type and grade.

Authors:  Parvin Mahzouni; Mohsen Jafari
Journal:  J Res Med Sci       Date:  2012-02       Impact factor: 1.852

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.